Keystone Healthcare

FUTURE OF HEALTHCARE

MedHQ | April 26, 2022

Becker Health, a leading provider of specialist nursing and allied talent acquisition solutions for the health care industry, has been acquired by MedHQ, a major provider of human resources and financial management services to healthcare facilities across the country. MedHQ and Becker Health will work together to deliver healthcare staffing and executive search services to clients across the United States, including contract, contract-to-hire, and direct hire opportunities. These ca...

HEALTHTECH SECURITY, FUTURE OF HEALTHCARE

Magellan Health | December 07, 2022

Magellan Healthcare, Inc., the behavioral health division of Magellan Health, Inc., announced the launch of a first-to-market, value-based collaboration with Kyo Autism Therapy, LLC, a California-based Applied Behavior Analysis provider, to drive meaningful and objectively measurable outcomes for children with autism spectrum disorder. Magellan and Kyo will develop, build and test a value-based model for treatment planning and delivery to continuously improve care for children with ...

HEALTH TECHNOLOGY

Ivenix | April 01, 2022

Ivenix, Inc. announced that it has entered into a definitive agreement to be acquired by Fresenius Kabi, a global health care leader specializing in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. Ivenix’s advanced infusion system combined with Fresenius Kabi’s intravenous fluids and infusion therapy offerings will bring a comprehensive portfolio of infusion products to U.S. hospitals. The purchase price will be a combination of US$240 milli...

MedCity News | January 15, 2020

Although it faced a setback earlier this month when regulators put the kibosh on its deal to acquire a rival company, genetic sequencing equipment maker Illumina will leave the J.P. Morgan Healthcare Conference with two new partnering deals under its belt. The San Diego-based company and Swiss drug and diagnostics maker Roche said Monday that they had formed a partnership to increase availability of genomic testing to patients with cancers. The 15-year, non-exclusive partnership is meant to broa...